Legislation
SECTION 2401-B
Cancer incidence and environmental facility maps
Public Health (PBH) CHAPTER 45, ARTICLE 24, TITLE 1
* § 2401-b. Cancer incidence and environmental facility maps. 1. For
purposes of this section, "environmental facility" shall have the same
meaning as provided in section 3-0317 of the environmental conservation
law.
2. For purposes of this section, "cancer incidence and environmental
facility maps technical advisory group" or "technical advisory group"
shall mean the environmental public health tracking program technical
advisory group required by a cooperative agreement between the
department and the federal centers for disease control and prevention.
3. The technical advisory group shall make recommendations to the
department on the appropriate use and communication of the cancer
incidence and environmental facility maps. Such recommendations shall
consider the scientific strengths and limitations of such mapping and
overlay methodologies for cancer tracking and geospatial linking to
significant disease risk factors, and the appropriate means for
communicating such strengths and limitation to the public in an easily
discernible manner. The department shall consider the recommendations of
the technical advisory group when making the maps required by this
section available to the public.
4. The department, in consultation with the department of
environmental conservation and the technical advisory group, shall
establish and maintain a computer mapping system for plotting cancer
incidence and environmental facilities throughout the state, including
but not limited to cancer clusters. Such maps shall overlay locations of
environmental facilities with cancer incidences.
5. Cancer incidence and environmental facility maps shall include data
on the incidence of the following cancer types:
(a) lung and bronchus;
(b) female breast;
(c) urinary bladder (including in situ);
(d) brain and other nervous system;
(e) colon and rectum;
(f) non-Hodgkin lymphomas;
(g) leukemias;
(h) thyroid;
(i) liver/intrahepatic bile duct;
(j) kidney and renal pelvis;
(k) prostate;
(l) oral cavity and pharynx;
(m) stomach;
(n) esophagus;
(o) larynx;
(p) pancreas;
(q) corpus uterus;
(r) ovary;
(s) testis;
(t) mesothelioma;
(u) bone;
(v) nasal and nasopharynx; and
(w) soft tissue sarcomas.
6. Plotting of data for cancer incidence and environmental facility
maps shall be by census block, except in cases where such plotting could
disclose the identity of any person to whom the data relate, in which
case census blocks shall be aggregated for plotting to protect the
identity of such person. When such aggregation is required, the
department shall utilize the minimum number of census blocks practicable
to protect the identity of such person.
7. By March first, two thousand eleven the department shall make
available to the public information on cancer as designated by the
environmental public health tracking program of the centers for disease
control and prevention, and, in consultation with the department of
environmental conservation, current data on locations and type of
environmental facilities.
8. By June thirtieth, two thousand eleven the department shall make
available to the public cancer incidence and environmental facility maps
which show available information on the location of environmental
facilities and the total number of reported cancers by census block and
associated data for each reported cancer type listed in subdivision five
of this section.
9. The department shall make available to the public cancer incidence
and environmental facility maps in the manner described in subdivision
four of this section showing cancer clusters by cancer types. Prior to
plotting such data, the department shall use an appropriate statistical
method to detect statistical anomalies for the purpose of identifying
cancer clusters.
The department shall make such maps available on its public website,
and shall, in consultation with the department of environmental
conservation, update the maps not less than once every five years.
* NB Repealed May 1, 2028
purposes of this section, "environmental facility" shall have the same
meaning as provided in section 3-0317 of the environmental conservation
law.
2. For purposes of this section, "cancer incidence and environmental
facility maps technical advisory group" or "technical advisory group"
shall mean the environmental public health tracking program technical
advisory group required by a cooperative agreement between the
department and the federal centers for disease control and prevention.
3. The technical advisory group shall make recommendations to the
department on the appropriate use and communication of the cancer
incidence and environmental facility maps. Such recommendations shall
consider the scientific strengths and limitations of such mapping and
overlay methodologies for cancer tracking and geospatial linking to
significant disease risk factors, and the appropriate means for
communicating such strengths and limitation to the public in an easily
discernible manner. The department shall consider the recommendations of
the technical advisory group when making the maps required by this
section available to the public.
4. The department, in consultation with the department of
environmental conservation and the technical advisory group, shall
establish and maintain a computer mapping system for plotting cancer
incidence and environmental facilities throughout the state, including
but not limited to cancer clusters. Such maps shall overlay locations of
environmental facilities with cancer incidences.
5. Cancer incidence and environmental facility maps shall include data
on the incidence of the following cancer types:
(a) lung and bronchus;
(b) female breast;
(c) urinary bladder (including in situ);
(d) brain and other nervous system;
(e) colon and rectum;
(f) non-Hodgkin lymphomas;
(g) leukemias;
(h) thyroid;
(i) liver/intrahepatic bile duct;
(j) kidney and renal pelvis;
(k) prostate;
(l) oral cavity and pharynx;
(m) stomach;
(n) esophagus;
(o) larynx;
(p) pancreas;
(q) corpus uterus;
(r) ovary;
(s) testis;
(t) mesothelioma;
(u) bone;
(v) nasal and nasopharynx; and
(w) soft tissue sarcomas.
6. Plotting of data for cancer incidence and environmental facility
maps shall be by census block, except in cases where such plotting could
disclose the identity of any person to whom the data relate, in which
case census blocks shall be aggregated for plotting to protect the
identity of such person. When such aggregation is required, the
department shall utilize the minimum number of census blocks practicable
to protect the identity of such person.
7. By March first, two thousand eleven the department shall make
available to the public information on cancer as designated by the
environmental public health tracking program of the centers for disease
control and prevention, and, in consultation with the department of
environmental conservation, current data on locations and type of
environmental facilities.
8. By June thirtieth, two thousand eleven the department shall make
available to the public cancer incidence and environmental facility maps
which show available information on the location of environmental
facilities and the total number of reported cancers by census block and
associated data for each reported cancer type listed in subdivision five
of this section.
9. The department shall make available to the public cancer incidence
and environmental facility maps in the manner described in subdivision
four of this section showing cancer clusters by cancer types. Prior to
plotting such data, the department shall use an appropriate statistical
method to detect statistical anomalies for the purpose of identifying
cancer clusters.
The department shall make such maps available on its public website,
and shall, in consultation with the department of environmental
conservation, update the maps not less than once every five years.
* NB Repealed May 1, 2028